NorthStrive Biosciences Achieves Key Milestone in EL-32 Development
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 13 2026
0mins
Should l Buy ELAB?
Source: Newsfilter
- Production Optimization Initiated: NorthStrive Biosciences has successfully transferred the EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility, marking the initiation of a manufacturing optimization program aimed at increasing yield and establishing a cost-efficient, scalable process to support future clinical and commercial development.
- Dual-Action Therapy: EL-32 is a dual-action engineered probiotic therapeutic designed to target key biological regulators of muscle development and metabolic function, myostatin and activin-A, through an oral, gut-mediated delivery mechanism, offering a unique solution for patients undergoing GLP-1 receptor agonist weight loss therapy.
- Collaborative Development Strategy: The partnership between NorthStrive and Modulant Biosciences reflects a dual-track development strategy, where NorthStrive retains all rights to human therapeutic applications of EL-32 while Modulant holds an exclusive license for developing and commercializing EL-32-derived products for non-human animal health, maximizing the commercial potential across both markets.
- Data-Driven Optimization: Modulant Biosciences will leverage the third-party precision fermentation facility for upstream and downstream process development, applying data-driven optimization strategies to enhance yield and consistency, thereby establishing a robust foundation for IND-enabling activities and future good manufacturing practices (GMP) manufacturing.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ELAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ELAB
About ELAB
PMGC Holdings Inc. is a diversified holding company. Its wholly owned subsidiaries include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc. AGA Precision Systems LLC and NorthStrive Defense Tech LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines and therapeutic products. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. Pacific Sun Packaging, Inc. is a specialty packaging provider focused on high-precision, component-level packaging solutions for the electronics and information technology hardware industries. AGA Precision Systems LLC is a specialized computer numerical control machine shop. NorthStrive Defense Tech LLC is focused on identifying, acquiring, and commercializing advanced defense technologies, with an emphasis on drone and autonomous systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PMGC Secures $40 Million Funding to Boost Acquisition Plans
- Funding Boost for Acquisitions: PMGC Holdings announced a $40 million equity purchase facility, with an initial tranche of approximately $10 million aimed at acquisitions, automation investments, and workforce development, enhancing its market position in the aerospace and defense sectors.
- Stock Price Rebound: Following the funding announcement, ELAB shares rose over 8% in morning trading on Friday, poised to end a three-session losing streak that had seen a decline of around 25%, indicating market confidence in the company's growth potential.
- Expansion Strategy: Since 2025, PMGC has expanded through acquisitions, adding three CNC precision manufacturing businesses and a specialty IT packaging firm, which strengthens its capabilities in complex machining and medical applications, thereby solidifying its competitive edge in the market.
- Market Sentiment Analysis: Despite the positive funding news, retail sentiment on Stocktwits remains bearish, reflecting the stock's recent underperformance, with a nearly 90% decline this year, as concerns about dilution threaten the capital structure.
See More
PMGC Holdings Secures $40 Million Equity Financing
- Financing Agreement: PMGC Holdings has entered into a $40 million equity purchase facility with an institutional investor, with an initial tranche of approximately $10 million expected to be funded at closing, providing flexible capital for future acquisitions and investments.
- Acquisition Strategy Advancement: Over the past 12 months, PMGC has completed four acquisitions, building a growing portfolio focused on precision manufacturing in aerospace and defense, demonstrating the company's proactive positioning in industry consolidation.
- Rising Market Demand: With increasing U.S. defense spending and supply chain security priorities, PMGC anticipates sustained demand for domestically produced high-precision components, providing a strong market foundation for future business expansion.
- Long-Term Development Vision: PMGC plans to establish a vertically integrated precision manufacturing platform through ongoing acquisitions and technology investments, aiming to meet critical supply chain needs and create sustainable value for shareholders.
See More
NorthStrive Biosciences Achieves Key Milestone in EL-32 Development
- Production Optimization Initiated: NorthStrive Biosciences has successfully transferred the EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility, marking the initiation of a manufacturing optimization program aimed at increasing yield and establishing a cost-efficient, scalable process to support future clinical and commercial development.
- Dual-Action Therapy: EL-32 is a dual-action engineered probiotic therapeutic designed to target key biological regulators of muscle development and metabolic function, myostatin and activin-A, through an oral, gut-mediated delivery mechanism, offering a unique solution for patients undergoing GLP-1 receptor agonist weight loss therapy.
- Collaborative Development Strategy: The partnership between NorthStrive and Modulant Biosciences reflects a dual-track development strategy, where NorthStrive retains all rights to human therapeutic applications of EL-32 while Modulant holds an exclusive license for developing and commercializing EL-32-derived products for non-human animal health, maximizing the commercial potential across both markets.
- Data-Driven Optimization: Modulant Biosciences will leverage the third-party precision fermentation facility for upstream and downstream process development, applying data-driven optimization strategies to enhance yield and consistency, thereby establishing a robust foundation for IND-enabling activities and future good manufacturing practices (GMP) manufacturing.
See More
Pacific Sun Packaging to Exhibit at ITAD Europe 2026
- International Exhibition Participation: Pacific Sun Packaging will exhibit at ITAD Europe 2026 from April 15-16 in Nice, France, attracting over 1,200 professionals from the global IT asset disposition market, showcasing its innovative packaging solutions for electronics.
- Growing Market Demand: With accelerating data center refresh cycles and rising enterprise demand for secure, auditable IT asset disposition, the company's exhibition will facilitate direct engagement with decision-makers, potentially increasing its market share in the rapidly expanding secondary electronics and IT remarketing supply chain.
- Product Showcase: The company will present its protective packaging solutions at Booth #414, specifically designed for high-value IT hardware such as CPUs, GPUs, memory modules, and SSDs, ensuring safe transport and storage to meet global supply chain demands.
- Strategic Priorities: PMGC Holdings continues to pursue revenue growth, with international market expansion and new customer acquisition identified as key strategic priorities, and participation in the exhibition will further solidify its market position in the electronics and IT hardware packaging sector.
See More
AGA Signs Long-Term Agreement with Tier 1 Defense Company
- Long-Term Agreement: AGA Precision Systems LLC has executed a Long-Term Agreement with a globally recognized Tier 1 aerospace and defense company, formalizing a multi-year supplier-customer relationship that further solidifies AGA's position within the U.S. defense supply chain.
- Supply Chain Commitments: Under the agreement, AGA will supply precision CNC-manufactured components to support the customer's aerospace and defense programs, ensuring compliance with quality, delivery, and pricing standards required for high-consequence, mission-critical defense applications.
- Increased Market Confidence: This agreement reflects the maturity of AGA's precision manufacturing capabilities and the confidence of its customers in AGA's ability to meet stringent technical and regulatory requirements, enhancing AGA's market position as a reliable, qualified supplier.
- Enhanced Revenue Potential: The signing of this long-term agreement provides AGA with operational visibility, supports recurring revenue potential, and reinforces its significant role within the broader U.S. aerospace and defense industrial base.
See More
AGA Precision Systems Enters Second Long-Term Supply Agreement for Aerospace and Defense Components with Tier 1 Company
Supply Agreement: AGA Precision Systems has signed a long-term supply agreement to manufacture aerospace and defense components.
Client Focus: The agreement specifically targets Tier 1 firms in the aerospace and defense sectors.
See More
PMGC Secures $40 Million Funding to Boost Acquisition Plans
- Funding Boost for Acquisitions: PMGC Holdings announced a $40 million equity purchase facility, with an initial tranche of approximately $10 million aimed at acquisitions, automation investments, and workforce development, enhancing its market position in the aerospace and defense sectors.
- Stock Price Rebound: Following the funding announcement, ELAB shares rose over 8% in morning trading on Friday, poised to end a three-session losing streak that had seen a decline of around 25%, indicating market confidence in the company's growth potential.
- Expansion Strategy: Since 2025, PMGC has expanded through acquisitions, adding three CNC precision manufacturing businesses and a specialty IT packaging firm, which strengthens its capabilities in complex machining and medical applications, thereby solidifying its competitive edge in the market.
- Market Sentiment Analysis: Despite the positive funding news, retail sentiment on Stocktwits remains bearish, reflecting the stock's recent underperformance, with a nearly 90% decline this year, as concerns about dilution threaten the capital structure.
See More
PMGC Holdings Secures $40 Million Equity Financing
- Financing Agreement: PMGC Holdings has entered into a $40 million equity purchase facility with an institutional investor, with an initial tranche of approximately $10 million expected to be funded at closing, providing flexible capital for future acquisitions and investments.
- Acquisition Strategy Advancement: Over the past 12 months, PMGC has completed four acquisitions, building a growing portfolio focused on precision manufacturing in aerospace and defense, demonstrating the company's proactive positioning in industry consolidation.
- Rising Market Demand: With increasing U.S. defense spending and supply chain security priorities, PMGC anticipates sustained demand for domestically produced high-precision components, providing a strong market foundation for future business expansion.
- Long-Term Development Vision: PMGC plans to establish a vertically integrated precision manufacturing platform through ongoing acquisitions and technology investments, aiming to meet critical supply chain needs and create sustainable value for shareholders.
See More
NorthStrive Biosciences Achieves Key Milestone in EL-32 Development
- Production Optimization Initiated: NorthStrive Biosciences has successfully transferred the EL-32 Working Cell Bank to a U.S.-based third-party fermentation facility, marking the initiation of a manufacturing optimization program aimed at increasing yield and establishing a cost-efficient, scalable process to support future clinical and commercial development.
- Dual-Action Therapy: EL-32 is a dual-action engineered probiotic therapeutic designed to target key biological regulators of muscle development and metabolic function, myostatin and activin-A, through an oral, gut-mediated delivery mechanism, offering a unique solution for patients undergoing GLP-1 receptor agonist weight loss therapy.
- Collaborative Development Strategy: The partnership between NorthStrive and Modulant Biosciences reflects a dual-track development strategy, where NorthStrive retains all rights to human therapeutic applications of EL-32 while Modulant holds an exclusive license for developing and commercializing EL-32-derived products for non-human animal health, maximizing the commercial potential across both markets.
- Data-Driven Optimization: Modulant Biosciences will leverage the third-party precision fermentation facility for upstream and downstream process development, applying data-driven optimization strategies to enhance yield and consistency, thereby establishing a robust foundation for IND-enabling activities and future good manufacturing practices (GMP) manufacturing.
See More
Pacific Sun Packaging to Exhibit at ITAD Europe 2026
- International Exhibition Participation: Pacific Sun Packaging will exhibit at ITAD Europe 2026 from April 15-16 in Nice, France, attracting over 1,200 professionals from the global IT asset disposition market, showcasing its innovative packaging solutions for electronics.
- Growing Market Demand: With accelerating data center refresh cycles and rising enterprise demand for secure, auditable IT asset disposition, the company's exhibition will facilitate direct engagement with decision-makers, potentially increasing its market share in the rapidly expanding secondary electronics and IT remarketing supply chain.
- Product Showcase: The company will present its protective packaging solutions at Booth #414, specifically designed for high-value IT hardware such as CPUs, GPUs, memory modules, and SSDs, ensuring safe transport and storage to meet global supply chain demands.
- Strategic Priorities: PMGC Holdings continues to pursue revenue growth, with international market expansion and new customer acquisition identified as key strategic priorities, and participation in the exhibition will further solidify its market position in the electronics and IT hardware packaging sector.
See More
AGA Signs Long-Term Agreement with Tier 1 Defense Company
- Long-Term Agreement: AGA Precision Systems LLC has executed a Long-Term Agreement with a globally recognized Tier 1 aerospace and defense company, formalizing a multi-year supplier-customer relationship that further solidifies AGA's position within the U.S. defense supply chain.
- Supply Chain Commitments: Under the agreement, AGA will supply precision CNC-manufactured components to support the customer's aerospace and defense programs, ensuring compliance with quality, delivery, and pricing standards required for high-consequence, mission-critical defense applications.
- Increased Market Confidence: This agreement reflects the maturity of AGA's precision manufacturing capabilities and the confidence of its customers in AGA's ability to meet stringent technical and regulatory requirements, enhancing AGA's market position as a reliable, qualified supplier.
- Enhanced Revenue Potential: The signing of this long-term agreement provides AGA with operational visibility, supports recurring revenue potential, and reinforces its significant role within the broader U.S. aerospace and defense industrial base.
See More
AGA Precision Systems Enters Second Long-Term Supply Agreement for Aerospace and Defense Components with Tier 1 Company
Supply Agreement: AGA Precision Systems has signed a long-term supply agreement to manufacture aerospace and defense components.
Client Focus: The agreement specifically targets Tier 1 firms in the aerospace and defense sectors.
See More
